Times Square Capital Management, LLC Merus N.V. Transaction History
Times Square Capital Management, LLC
- $6.51 Billion
- Q4 2024
A detailed history of Times Square Capital Management, LLC transactions in Merus N.V. stock. As of the latest transaction made, Times Square Capital Management, LLC holds 331,195 shares of MRUS stock, worth $13.3 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
331,195
Previous 272,435
21.57%
Holding current value
$13.3 Million
Previous $13.6 Million
2.32%
% of portfolio
0.21%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
63MCall Options Held
297KPut Options Held
117K-
Rtw Investments, LP New York, NY4.17MShares$168 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$156 Million16.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$141 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$120 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$107 Million1.81% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.84B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...